Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06401863 · ClinicalTrials.gov registry record · NA
Shared Decision for Drug Interactions in Oral Anticoagulation
A NA study of Drug Interactions and Anticoagulants, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 3,691
- Enrollment target
- 3
- Study locations
NCT06401863: Recruiting NA study of Drug Interactions and Anticoagulants, sponsored by University of Utah.
NCT06401863 is a NA study of Drug Interactions and Anticoagulants that is actively recruiting participants, run by University of Utah. The registered enrollment target is 3,691 participants, above the 115-participant average among 6 other Drug Interactions trials with a reported enrollment target (3110% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06401863, a NA study of Drug Interactions and Anticoagulants, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,691 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this project is to implement and evaluate a shared-decision making (SDM) tool called DDInteract that was developed to support decision making for drug-drugs interactions while on oral anticoagulants. DDInteract will be implemented in clinics at the University of Utah, University of Colorado and University of Vanderbilt. DDInteract will be launched from within the electronic health record (EHR) retrieving patient-specific risk factors, will calculate the risk of harm, and will allow providers and patients to dynamically explore "what if" scenarios to optimize treatment and minimize risk. DDInteract will enable shared-decision making using individually-tailored information on the potential benefits and harms of drug interactions in anticoagulated patients.
Primary Outcome
We will compare population Gastrointestinal Bleeding risk across the randomized clinics before and after implementation of DDInteract
Conditions Studied
Interventions
- OTHER Shared Decision Making Tool
Study Locations (3)
Colorado
- University of Colorado. School of Medicine - Denver
Tennessee
- Vanderbilt University - Nashville
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,691 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT06401863 shows while recruiting
NCT06401863 is an interventional study that assigns participants to a tested intervention. Its 3,691 participants enrollment target places it among the larger protocols in the corpus, above the 115-participant average among 6 other Drug Interactions trials with a reported enrollment target (3110% higher).
The record links to 2 conditions, with Drug Interactions appearing as the primary indexed condition, and to 1 intervention - of which Shared Decision Making Tool is the first listed.
NCT06401863 reports a single indexed study location in Colorado, Tennessee, Utah.
Frequently Asked Questions
What is clinical trial NCT06401863 about?
NCT06401863 is a clinical study titled "Shared Decision for Drug Interactions in Oral Anticoagulation". The purpose of this project is to implement and evaluate a shared-decision making (SDM) tool called DDInteract that was developed to support decision making for drug-drugs interactions while on oral anticoagulants. DDInteract will be implemented in clinics at the University of Utah, University of Co...
What is the current status of trial NCT06401863?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,691 participants. The study started on 2023-10-01. Estimated completion is 2026-07-31.
What conditions does trial NCT06401863 study?
This clinical trial studies the following conditions: Drug Interactions, Anticoagulants.
What interventions are being tested in trial NCT06401863?
The interventions under investigation include: Shared Decision Making Tool (OTHER).
Who is sponsoring clinical trial NCT06401863?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06401863 being conducted?
This trial has 3 study locations across Colorado, Tennessee, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Interactions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Emergency Department (ED) Drug Interaction in Emergency Department Patients
COMPLETED · NA
-
Opioid Drug Interaction Study
RECRUITING · Phase 1
-
LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
RECRUITING · Phase 4
-
Phase 1, Open-label, Drug-drug Interaction Study With Octreotide Acetate Injection and Telotristat Etiprate in Healthy Subjects
COMPLETED · Phase 1
-
Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)
COMPLETED · Phase 1
-
Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06784960 · 3,689 participants · NA
Communication Strategies to Increase HPV Vaccination Intention
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- NCT06076304 · 3,720 participants · Phase 4
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
- NCT06702553 · 3,650 participants · Phase 3
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI